Abstract

Rhabdomyosarcoma (RMS) is a soft tissue sarcoma that histologically resembles embryonic skeletal muscle. It can occur anywhere in the body, including tissues devoid of skeletal muscles. RMS is a common malignancy in children, and it accounts for ˃50% of all soft tissue sarcomas in children. Embryonal rhabdomyosarcoma (ERMS) mostly affects children younger than 10 years of age. The head and neck area, the genitourinary tract and the retroperitoneum are described as the preferred anatomic sites for ERMS development. However, the mesentery location is extremely rare. We report a rare case of an ERMS occurring in the mesentery of a 17-year-old male.

INTRODUCTION

Soft tissue sarcomas have an overall incidence of 7.15% in children [1]. Within this group of neoplasms, rhabdomyosarcomas (RMS) are most common [2]. Embryonal rhabdomyosarcoma (ERMS), followed by alveolar rhabdomyosarcoma (ARMS), are common histological subtypes (~91%) [3]. RMS accounts for ˃50% of all soft tissue sarcomas in children [4]. ERMS mostly affects children younger than 10 years of age, but also occurs in adolescents and young adults [5].

RMS originates from embryonal mesenchyme that differentiates into skeletal muscle [2]. It can occur anywhere in the body, including tissues devoid of skeletal muscles. The cell of origin remains unknown. Recent evidence suggests that RMS may originate from aberrant development of non-myogenic cells [6]. The head and neck region, genitourinary tract and retroperitoneum are the most common anatomic sites for ERMS [3]. The mesenteric location is extremely rare and only a few cases are reported [7–9]. In this case report, we discuss the findings of a mesenteric RMS in an adolescent.

CASE PRESENTATION

A 17-year-old male presented with progressive abdominal swelling for 1 month. The swelling worsened 3 days prior to admission and was associated with abdominal pain that radiated to the groins. The patient reported anorexia, nausea and vomiting. He also reported hiccups, fever, generalized body weakness and weight loss. On examination, he was afebrile with mild pallor and left inguinal lymphadenopathy. The abdomen was distended with guarding and tenderness in the right lower quadrant with an ill-defined mass measuring 6 cm × 8 cm. There were reduced bowel sounds and positive shifting dullness. Laboratory values were significant for serum sodium of 120.7 mmol/L (ref. 136–145 mmol/L) and chloride of 86.7 mmol/L (ref. 98–107 mmol/L). Complete blood count and all other serum electrolytes were within normal limits. An erect chest X-ray showed air under the diaphragm.

The patient was taken to the operative theater. Peritoneal spillage with an ileal perforation ~40 cm from the ileocecal junction was noted (Fig. 1). A fixed, friable, tumor with neovascularization was noted involving the mesentery of the ileum. Tissue was obtained for histology. Due to the inability to completely resect the mass, the perforation was repaired primarily and an ileostomy ~30 cm from the ligament of Treitz was performed.

Intraoperative view showing the perforation in the ileum due to the mesenteric tumor (arrow).
Figure 1

Intraoperative view showing the perforation in the ileum due to the mesenteric tumor (arrow).

Histology confirmed the presence of a high-grade malignancy. The tissue consisted of fibrous connective tissue and fat. The malignant infiltrate was composed of plump epithelioid cells and occasional spindle cells with pleomorphism. Many of the cells had eosinophilic cytoplasmic inclusions that appeared rhabdoid. Nucleoli, mitotic figures and necrosis were noted (Fig. 2). The histological features favored sarcoma with rhabdoid morphology with a provisional diagnosis of embryonal RMS. The patient was referred to the national cancer institute for further management where he expired before any intervention.

Istopathological analysis. (a) There is densely cellular tumor infiltrates without any discernable pattern. The intercellular matrix consists of sparse fibrous tissue. (b) The majority of the tumor cells appear undifferentiated with hyperchromatic oval to round nuclei with scant cytoplasm. Most of the cells are epithelioid with occasional spindle cells. (c) Occasional mitotic figures are seen. (d) Some cells have eccentric nuclei and abundant pink cytoplasm typical of rhabdomyoblasts.
Figure 2

Istopathological analysis. (a) There is densely cellular tumor infiltrates without any discernable pattern. The intercellular matrix consists of sparse fibrous tissue. (b) The majority of the tumor cells appear undifferentiated with hyperchromatic oval to round nuclei with scant cytoplasm. Most of the cells are epithelioid with occasional spindle cells. (c) Occasional mitotic figures are seen. (d) Some cells have eccentric nuclei and abundant pink cytoplasm typical of rhabdomyoblasts.

DISCUSSION

RMS is the most common soft tissue sarcoma in children and adolescents [10]. There is slight male predominance [11, 12]. Black patients in the United States were shown to have the highest incidence of RMS [12]. In Eastern Africa, cases of RMS range from 2.6 to 16.3 per million [11]. The two most common histologic variants in children and adolescents are ERMS and ARMS. ERMS occurs in childhood with a peak age of onset ˂5 years of age [13].

Histologically, RMS can be classified into three subtypes: embryonal (67%), alveolar (32%) and pleomorphic (1%). In contrast to pleomorphic and alveolar subtypes, ERMS is more likely to present without distant metastasis [7]. Symptoms are non-specific and often depend on the location and size of the tumor [7, 10]. ERMS primarily involves the head and neck region, genitourinary tract and retroperitoneum [3]. Our patient had ERMS located at the mesentery, a rare location. Despite the diagnosis of ERMS, our patient also likely had metastasis to the inguinal lymph nodes.

RMS is difficult to diagnose due to its rarity and clinical and biological variation [14]. Imaging studies should include computed tomography scan or magnetic resonance imaging to determine the size and involvement of surrounding organs. For tumors arising from the head, imaging studies should also include full views of the neck to evaluate the cervical lymph node chains. Open biopsy of the mass is often used to confirm the diagnosis [15].

Standard chemotherapy regimens include vincristine, actinomycin-D and cyclophosphamide [16]. Agents such as carboplatin, irinotecan, topotecan and vinorelbine have shown significant efficacy in the treatment of pediatric patients with metastatic, relapsing or refractory RMS [17, 18]. Surgery is the mainstay of treatment regardless of stage or risk factors. Complete resection is indicated if possible, as it has been shown to improve survival. Margins of 0.5 cm are recommended in children as larger margins are unfeasible due to tissue limitations [16]. In our case, the patient presented late, and the tumor was unresectable.

Radiotherapy is beneficial for advanced disease. It is used to control residual bulky or microscopic tumors, especially when the tumor is unresectable [18, 19]. Surgery to resect residual disease can eliminate the need for adjuvant radiation, which is recommended for all patients except those with margin-negative RMS [14].

Historically, patients with RMS were believed to have a dismal prognosis. However, for pediatric patients with early localized disease, located in favorable sites with favorable histological types, aggressive multimodality therapy gives long-term survival rates of 90% . The prognostic risk factors include the site of the primary tumor, the extent of the initial surgical resection, age at diagnosis, histologic type, tumor-node-metastasis stage and most importantly, response to treatment. The 10-year metastasis-free survival was 72% for patients with RMS who responded to chemotherapy compared to 19% for patients who failed to respond [20]. The tumor in our case was mesenteric, a rare site, with poor prognosis.

CONCLUSION

Rhabdomyosarcoma is prevalent in children and teenagers. There are only a few cases of embryonal rhabdomyosarcoma within the mesentery. Although uncommon, the mesentery as the primary location of this tumor should be kept in mind as a differential diagnosis for intraperitoneal tumors. Early diagnosis can lead to an increased chance of complete resection and improved prognosis.

CONFLICT OF INTEREST STATEMENT

The authors declare not conflicts of interest.

FUNDING

None.

DATA AVAILABILITY

Data sharing is not applicable is not applicable to this article as no new data were created or analyzed in this study.

References

1.

Li
 
J
,
Thompson
 
TD
,
Miller
 
JW
,
Pollack
 
LA
,
Stewart
 
SL
.
Cancer incidence among children and adolescents in the United States, 2001–2003
.
Pediatrics
 
2008
;
121
:
e1470
7
.

2.

Malempati
 
S
,
Hawkins
 
DS
.
Rhabdomyosarcoma: review of the Children’s oncology group (COG) soft-tissue sarcoma committee experience and rationale for current COG studies
.
Pediatr Blood Cancer
 
2012
;
59
:
5
10
.

3.

Ward
 
E
,
DeSantis
 
C
,
Robbins
 
A
,
Kohler
 
B
,
Jemal
 
A
.
Childhood and adolescent cancer statistics, 2014
.
CA Cancer J Clin
 
2014
;
64
:
83
103
.

4.

Pastore
 
G
,
Peris-Bonet
 
R
,
Carli
 
M
,
Martínez-García
 
C
,
de
 
Toledo
 
JS
,
Steliarova-Foucher
 
E
.
Childhood soft tissue sarcomas incidence and survival in European children (1978–1997): report from the automated childhood cancer information system project
.
Eur J Cancer
 
2006
;
42
:
2136
49
.

5.

Goldblum
 
JR
,
Weiss
 
SW
,
Folpe
 
AL
. Rhabdomyosarcoma. In:
Enzinger and Weiss’s Soft Tissue Tumors
, 7th edn.
Philadelphia
:
Elsevier
,
2019
,
652
98
.

6.

Drummond
 
CJ
,
Hanna
 
JA
,
Garcia
 
MR
,
Devine
 
DJ
,
Heyrana
 
AJ
,
Finkelstein
 
D
, et al.   
Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors
.
Cancer Cell
 
2018
;
33
:
108
124.e5
.

7.

Benradi
 
L
,
El Haissoufi
 
K
,
Ammor
 
A
,
Haloui
 
A
,
Bennani
 
A
,
El Azzouzi
 
D
, et al.   
Embryonal rhabdomyosarcoma in the sigmoid mesentery
.
J Pediatr Surg Case Rep
 
2021
;
69
:
101869
.

8.

Al-salem
 
AH
,
Parida
 
L
,
Al-Wabari
 
A
.
Rhabdomyosarcoma of the mesentery in an infant
.
Med Case Stud
 
2012
;
3
:
21
5
.

9.

Agarwal
 
K
,
Kulshrestha
 
R
,
Pahuja
 
S
,
Chadha
 
R
.
Botryoid rhabdomyosarcoma of mesentery--a case report
.
Indian J Pathol Microbiol
 
2003
;
46
:
457
9
.

10.

Dasgupta
 
R
,
Rodeberg
 
DA
.
Update on rhabdomyosarcoma
.
Semin Pediatr Surg
 
2012
;
21
:
68
78
.

11.

Martin-Giacalone
 
BA
,
Weinstein
 
PA
,
Plon
 
SE
,
Lupo
 
PJ
.
Pediatric rhabdomyosarcoma: epidemiology and genetic susceptibility
.
J Clin Med
 
2021
;
10
:
2028
.

12.

Friedrich
 
P
,
Itriago
 
E
,
Rodriguez-Galindo
 
C
,
Ribeiro
 
K
.
Racial and ethnic disparities in the incidence of Pediatric Extracranial embryonal Tumors
.
J Natl Cancer Inst
 
2017
;
109
.

13.

Ferrari
 
A
,
Dileo
 
P
,
Casanova
 
M
,
Bertulli
 
R
,
Meazza
 
C
,
Gandola
 
L
, et al.   
Rhabdomyosarcoma in adults
.
Cancer
 
2003
;
98
:
571
80
.

14.

Borinstein
 
SC
,
Steppan
 
D
,
Hayashi
 
M
,
Loeb
 
DM
,
Isakoff
 
MS
,
Binitie
 
O
, et al.   
Consensus and controversies regarding the treatment of rhabdomyosarcoma
.
Pediatr Blood Cancer
 
2018
;
65
:
e26809
.

15.

Huh
 
W
,
Egas
 
BD
.
Rhabdomyosarcoma in adolescent and young adult patients: current perspectives
.
Adolesc Health Med Ther
 
2014
;
5
:
115
25
.

16.

Dasgupta
 
R
,
Fuchs
 
J
,
Rodeberg
 
D
.
Rhabdomyosarcoma
.
Semin Pediatr Surg
 
2016
;
25
:
276
83
.

17.

Setty
 
BA
,
Stanek
 
JR
,
Mascarenhas
 
L
,
Miller
 
A
,
Bagatell
 
R
,
Okcu
 
F
, et al.   
Vincristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma
.
Pediatr Blood Cancer
 
2018
;
65
:
e26728
.

18.

Defachelles
 
AS
,
Bogart
 
E
,
Casanova
 
M
,
Merks
 
JHM
,
Bisogno
 
G
,
Calareso
 
G
, et al.   
Randomized phase II trial of vincristine-Irinotecan with or without Temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: a European paediatric soft tissue sarcoma study group and innovative therapies for children with cancer trial
.
J Clin Oncol
 
2021
;
39
:
2979
90
.

19.

Terezakis
 
SA
,
Wharam
 
MD
.
Radiotherapy for rhabdomyosarcoma: indications and outcome
.
Clin Oncol
 
2013
;
25
:
27
35
.

20.

Chen
 
J
,
Liu
 
X
,
Lan
 
J
,
Li
 
T
,
She
 
C
,
Zhang
 
Q
,
Yang
 
W
.
Rhabdomyosarcoma in adults: case series and literature review
.
Int J Womens Health
2022;
14
:405–14.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.